Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TATX-03E
- Development stage
- Preclinical
- Lead developer
- ImmunoPrecise Antibodies
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
TATX-03E is a high-concentration, alternative formulation of the PolyTope® TATX-03 antibody cocktail developed for the treatment and prevention of COVID-19. It is designed to be easily self-administered outside healthcare settings, enabling rapid deployment and field use, particularly for immunocompromised individuals who may require ongoing access to antibody therapies or prophylaxis. The original PolyTope® TATX-03 consists of multiple synergistic human IgG1 monoclonal antibodies targeting diverse epitopes on SARS-CoV-2, aiming to provide broad neutralization across variants and reduce mutagenic escape risk. Preclinical studies have demonstrated strong efficacy in both therapeutic and prophylactic models against SARS-CoV-2 infection[1][2][3].
- Brand names
- TATX-03ETATX03ETATX 03E
- Other names
- PolyTope TATX-03E
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on TATX-03E.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TATX-03E.